BlueCrest Capital Management’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-39,550
Closed -$2.95M 400
2020
Q3
$2.95M Buy
+39,550
New +$2.74M 0.11% 150
2018
Q4
Sell
-6,452
Closed -$464K 1261
2018
Q3
$464K Buy
+6,452
New +$406K 0.01% 793
2018
Q2
Sell
-7,695
Closed -$334K 1722
2018
Q1
$334K Buy
+7,695
New +$354K 0.01% 989

Other funds holding OMCL

BlueCrest Capital Management's OMCL Position: Q4 2020 in Review

BlueCrest Capital Management sold out of Omnicell (OMCL) in Q4 2020, closing a stake of 39,550 shares — an estimated $2.95M sold.

BlueCrest Capital Management first reported a position in OMCL in Q1 2018 and held it in 3 quarters. The position peaked at $2.95M in Q3 2020. 354 funds tracked by Wall St. Rank hold OMCL as of Q4 2020.

  • BlueCrest Capital Management reported no remaining Omnicell position as of Q4 2020 after selling out during the quarter.
  • BlueCrest Capital Management sold 39,550 Omnicell shares in Q4 2020, an estimated $2.95M.
  • BlueCrest Capital Management first reported a position in Omnicell in Q1 2018 and held it in 3 quarters.
  • BlueCrest Capital Management's Omnicell position peaked at $2.95M in Q3 2020.
  • 354 funds tracked by Wall St. Rank held Omnicell as of Q4 2020.

Based on BlueCrest Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.